Prospective study of the correlation between admission plasma homocysteine levels and neurological outcome following subarachnoid hemorrhage: A case for the reverse epidemiology paradox?

• Published in: Acta neurochirurgica 2015-03, Vol.157 (3), p.399-407
• Main Authors: Dhandapani, Sivashanmugam, Goudihalli, Sachin, Mukherjee, Kanchan K., Singh, Harnarayan, Srinivasan, Anirudh, Danish, Mohammad, Mahalingam, Shanthanam, Dhandapani, Manju, Gupta, Sunil K., Khandelwal, N., Mathuriya, Suresh N.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Clinical Article - Vascular; Female; Glasgow Outcome Scale; Homocysteine - blood; Humans; Interventional Radiology; Male; Medicine; Medicine & Public Health; Middle Aged; Minimally Invasive Surgery; Multivariate Analysis; Neurology; Neuroradiology; Neurosurgery; Prognosis; Prospective Studies; Risk Factors; Subarachnoid Hemorrhage - blood; Subarachnoid Hemorrhage - diagnosis; Subarachnoid Hemorrhage - epidemiology; Surgical Orthopedics
• ISSN: 0001-6268; 0942-0940
• DOI: 10.1007/s00701-014-2297-0

Background Homocysteine (tHcy) has been known over the last few decades for its putative impact on vascular diseases, but has not been evaluated much in patients with subarachnoid hemorrhage (SAH). This study was carried out to assess its prognostic impact on the neurological outcome following SAH. Methods Admission plasma tHcy was evaluated in 90 SAH patients and prospectively studied in relation to various factors and the Glasgow Outcome Scale (GOS) at 3 months. Univariate and multivariate analyses were performed using SPSS 21. Results tHcy was significantly higher following SAH compared to matched controls [median (IQR): 25.7 (17.3–35.9) vs. 14.0 (9.8–17.6) μmol/l, p